Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis

Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis Prostate Cancer and Prostatic Diseases advance online publication, April 25 2017. doi:10.1038/pcan.2017.23 Authors: R J S Calopedos, V Chalasani, R Asher, L Emmett & H H Woo
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research